Literature DB >> 6885675

Hypoprothrombinemia and platelet dysfunction caused by cephalosporin and oxalactam antibiotics.

C R Smith, J J Lipsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6885675     DOI： 10.1093/jac/11.6.496

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  10 in total

1.  Unreviewed reports.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-08

2.  Effects of N-methyl-thiotetrazole cephalosporin on haemostasis in patients with reduced serum vitamin K1 concentrations.

Authors:  I J Mackie; K Walshe; H Cohen; P McCarthy; M Shearer; S D Scott; S J Karran; S J Machin
Journal:  J Clin Pathol       Date:  1986-11       Impact factor: 3.411

3.  Cefoperazone compared with ampicillin plus tobramycin for severe biliary tract infections.

Authors:  M G Bergeron; J Mendelson; G K Harding; L Mandell; I W Fong; A Rachlis; R Chan; S Biron; R Feld; N B Segal
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

4.  Effect of temocillin and moxalactam on platelet responsiveness and bleeding time in normal volunteers.

Authors:  B Nunn; A Baird; P D Chamberlain
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

5.  Production of hypoprothrombinemia by moxalactam and 1-methyl-5-thiotetrazole in rats.

Authors:  J J Lipsky; J C Lewis; W J Novick
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

6.  Mechanism of the inhibition of the gamma-carboxylation of glutamic acid by N-methylthiotetrazole-containing antibiotics.

Authors:  J J Lipsky
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

7.  Cefmenoxime pharmacokinetics in patients with renal insufficiency.

Authors:  R E Polk; D A Sica; T M Kerkering; B J Kline; P M Patterson; J W Baggett
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

Review 8.  Clinical pharmacokinetics of the third generation cephalosporins.

Authors:  L Balant; P Dayer; R Auckenthaler
Journal:  Clin Pharmacokinet       Date:  1985 Mar-Apr       Impact factor: 6.447

9.  Clinical risk factors for prolonged PT/PTT in abdominal sepsis patients treated with moxalactam or tobramycin plus clindamycin.

Authors:  J G Baxter; D A Marble; L R Whitfield; P B Wels; P Walczak; J J Schentag
Journal:  Ann Surg       Date:  1985-01       Impact factor: 12.969

10.  Prospects for new antibiotics: keeping one step ahead.

Authors:  D Greenwood
Journal:  J R Coll Physicians Lond       Date:  1985-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.